NOT KNOWN DETAILS ABOUT SODIUM PHENOBARBITAL SOLUBILITY

Contraindicated (1)pentobarbital will reduce the extent or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers may end up in lessened serum concentrations and lack of antimalarial efficacyDemise penalty opponents also are concerned that Barr’s determination